School-Based Serosurveys to Assess the Validity of Using Routine Health Facility Data to Target Malaria Interventions in the Central Highlands of Madagascar.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
29 03 2021
Historique:
received: 02 03 2020
accepted: 28 07 2020
pubmed: 8 8 2020
medline: 11 2 2022
entrez: 8 8 2020
Statut: ppublish

Résumé

In low-malaria-transmission areas of Madagascar, annual parasite incidence (API) from routine data has been used to target indoor residual spraying at subdistrict commune level. To assess validity of this approach, we conducted school-based serological surveys and health facility (HF) data quality assessments in 7 districts to compare API to gold-standard commune-level serological measures. At 2 primary schools in each of 93 communes, 60 students were randomly selected with parents and teachers. Capillary blood was drawn for rapid diagnostic tests (RDTs) and serology. Multiplex bead-based immunoassays to detect antibodies to 5 Plasmodium falciparum antigens were conducted, and finite mixture models used to characterize seronegative and seropositive populations. Reversible catalytic models generated commune-level annual seroconversion rates (SCRs). HF register data were abstracted to assess completeness and accuracy. RDT positivity from 12 770 samples was 0.5%. Seroprevalence to tested antigens ranged from 17.9% (MSP-1) to 59.7% (PF13). Median commune-level SCR was 0.0108 (range, 0.001-0.075). Compared to SCRs, API identified 71% (95% confidence interval, 51%-87%) of the 30% highest-transmission communes; sensitivity declined at lower levels. Routine data accuracy did not substantially affect API performance. API performs reasonably well at identifying higher-transmission communes but sensitivity declined at lower transmission levels.

Sections du résumé

BACKGROUND
In low-malaria-transmission areas of Madagascar, annual parasite incidence (API) from routine data has been used to target indoor residual spraying at subdistrict commune level. To assess validity of this approach, we conducted school-based serological surveys and health facility (HF) data quality assessments in 7 districts to compare API to gold-standard commune-level serological measures.
METHODS
At 2 primary schools in each of 93 communes, 60 students were randomly selected with parents and teachers. Capillary blood was drawn for rapid diagnostic tests (RDTs) and serology. Multiplex bead-based immunoassays to detect antibodies to 5 Plasmodium falciparum antigens were conducted, and finite mixture models used to characterize seronegative and seropositive populations. Reversible catalytic models generated commune-level annual seroconversion rates (SCRs). HF register data were abstracted to assess completeness and accuracy.
RESULTS
RDT positivity from 12 770 samples was 0.5%. Seroprevalence to tested antigens ranged from 17.9% (MSP-1) to 59.7% (PF13). Median commune-level SCR was 0.0108 (range, 0.001-0.075). Compared to SCRs, API identified 71% (95% confidence interval, 51%-87%) of the 30% highest-transmission communes; sensitivity declined at lower levels. Routine data accuracy did not substantially affect API performance.
CONCLUSIONS
API performs reasonably well at identifying higher-transmission communes but sensitivity declined at lower transmission levels.

Identifiants

pubmed: 32761176
pii: 5881873
doi: 10.1093/infdis/jiaa476
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

995-1004

Informations de copyright

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Auteurs

Laura C Steinhardt (LC)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Elisabeth Ravaoarisoa (E)

Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Faculty of Sciences, University of Antananarivo, Antananarivo, Madagascar.

Ryan Wiegand (R)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Aina Harimanana (A)

Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Judith Hedje (J)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
US President's Malaria Initiative, Antananarivo, Madagascar.

Annett H Cotte (AH)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sixte Zigirumugabe (S)

US President's Malaria Initiative, Antananarivo, Madagascar.
United States Agency for International Development, Washington, District of Columbia, USA.

Thomas Kesteman (T)

Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Fondation Merieux, Lyon, France.

Tsikiniaina L Rasoloharimanana (TL)

Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Emma Rakotomalala (E)

Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Anny M Randriamoramanana (AM)

Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Jean-Marius Rakotondramanga (JM)

Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Seheno Razanatsiorimalala (S)

Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Odile Mercereau-Puijalon (O)

Parasites and Insect Vectors Department, Institut Pasteur, Paris, France.

Ronald Perraut (R)

Immunology Unit, Institut Pasteur de Dakar, Dakar, Senegal.

Arsène Ratsimbasoa (A)

National Malaria Control Program of Madagascar, Ministry of Public Health, Antananarivo, Madagascar.
Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar.
L'Institut Hospitalo-Universitaire en Maladies Infectieuses de Marseille, Marseille, France.

Jessica Butts (J)

Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Christophe Rogier (C)

L'Institut Hospitalo-Universitaire en Maladies Infectieuses de Marseille, Marseille, France.
Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Patrice Piola (P)

Epidemiology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
Epidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.

Milijaona Randrianarivelojosia (M)

Malaria Research Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Inès Vigan-Womas (I)

Immunology of Infectious Diseases Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH